Category: MED


COULD THERE BE A MORAL USE OF A CONDOM?

alt

"THOSE WHO ARE USING A CONDOM TO AVOID THE TRANSMISSION OF HIV SHOULD FOLLOW OUT THE LOGIC OF THEIR THOUGHT. THE REASON THEY’RE USING A CONDOM IS BECAUSE THEY DON’T WANT TO GET OR DON’T WANT TO TRANSMIT A SEXUALLY TRANSMITTED DISEASE. THEIR NEXT THOUGHT SHOULD BE: WHY AM I ENGAGING IN AN ACT THAT MIGHT TRANSMIT THE HIV AND KILL SOMEBODY OR MYSELF? MAYBE MY PRIORITIES ARE WRONG HERE, MAYBE SEXUAL PLEASURE SHOULDN’T BE THAT KIND OF PRIORITY THAT LEADS ME TO ENGAGE IN ACTS THAT COULD TRANSMIT A SEXUALLY TRANSMITTED DISEASE, A LETHAL ONE."

- JANET E. SMITH, A PROFESSOR OF MORAL THEOLOGY AT THE SACRED HEART MAYOR SEMINARY IN DETROIT IN THE UNITED STATES, IN AN INTERVIEW WITH DIANNE PENN FROM UNITED NATIONS RADIO IN NEW YORK, FOLLOWING COMMENTS BY POPE BENEDICT XVI ON CONDOM USE.

TOXOPLASMOSIS

42-19879541

TOXOPLASMOSIS IS A PARASITIC DISEASE CAUSED BY THE PROTOZOAN Toxoplasma gondii. THE PARASITE INFECTS MOST GENERA OF WARM-BLOODED ANIMALS, INCLUDING HUMANS, BUT THE PRIMARY HOST IS THE FELID (CAT) FAMILY. ANIMALS ARE INFECTED BY EATING INFECTED MEAT, BY INGESTION OF FECES OF A CAT THAT HAS ITSELF RECENTLY BEEN INFECTED, OR BY TRANSMISSION FROM MOTHER TO FETUS. CATS HAVE BEEN SHOWN AS A MAJOR RESERVOIR OF THIS INFECTION.

THE PARASITE ITSELF CAN CAUSE VARIOUS EFFECTS ON THE HOST BODY, SOME OF WHICH ARE NOT FULLY UNDERSTOOD.

REPRODUCTIVE CHANGES

A RECENT STUDY HAS INDICATED TOXOPLASMOSIS CORRELATES STRONGLY WITH AN INCREASE IN BOY BIRTHS IN HUMANS. ACCORDING TO THE RESEARCHERS, “DEPENDING ON THE ANTIBODY CONCENTRATION, THE PROBABILITY OF THE BIRTH OF A BOY CAN INCREASE UP TO A VALUE OF 0.72, WHICH MEANS THAT FOR EVERY 260 BOYS BORN, 100 GIRLS ARE BORN. “THE STUDY ALSO NOTES A MEAN RATE OF 0.608 (AS OPPOSED TO THE NORMAL 0.51) FOR TOXOPLASMA-POSITIVE MOTHERS. THE STUDY EXPLAINS THAT THIS EFFECT MAY NOT SIGNIFICANTLY INFLUENCE THE ACTUAL SEX RATIO OF CHILDREN BORN IN COUNTRIES WITH HIGH RATES OF LATENT TOXOPLASMOSIS INFECTION BECAUSE “IN HIGH-PREVALENCE COUNTRIES, MOST WOMEN OF REPRODUCTIVE AGE HAVE ALREADY BEEN INFECTED FOR A LONG TIME AND THEREFORE HAVE ONLY LOW TITRES OF ANTI-TOXOPLASMA ANTIBODIES. OUR RESULTS SUGGEST THAT LOW-TITRE WOMEN HAVE SIMILAR SEX RATIOS TO TOXOPLASMA-NEGATIVE WOMEN.”

BEHAVIORAL CHANGES

IT HAS BEEN FOUND THAT THE PARASITE HAS THE ABILITY TO CHANGE THE BEHAVIOUR OF ITS HOST: INFECTED RATS AND MICE ARE LESS FEARFUL OF CATS, IN FACT, SOME OF THE INFECTED RATS SEEK OUT CAT-URINE-MARKED AREAS. THIS EFFECT IS ADVANTAGEOUS TO THE PARASITE, WHICH WILL BE ABLE TO PROLIFERATE DUE TO THE FACT THAT A CAT COULD EAT THE INFECTED RAT AND THEN REPRODUCE. THE MECHANISM FOR THIS CHANGE IS NOT COMPLETELY UNDERSTOOD, BUT THERE IS EVIDENCE THAT TOXOPLASMOSIS INFECTION RAISES DOPAMINE LEVELS AND CONCENTRATES IN THE AMYGDALA IN INFECTED MICE.

THE FINDINGS OF BEHAVIOURAL ALTERATION IN RATS AND MICE HAVE LED SOME SCIENTISTS TO SPECULATE THAT Toxoplasma MAY HAVE SIMILAR EFFECTS IN HUMANS, EVEN IN THE LATENT PHASE THAT HAD PREVIOUSLY BEEN CONSIDERED ASYMPTOMATIC. Toxoplasma IS ONE OF A NUMBER OF PARASITES THAT MAY ALTER THEIR HOST’S BEHAVIOUR AS A PART OF THEIR LIFE CYCLE. THE BEHAVIORS OBSERVED, IF CAUSED BY THE PARASITE, ARE LIKELY DUE TO INFECTION AND LOW-GRADE ENCEPHALITIS, WHICH IS MARKED BY THE PRESENCE OF CYSTS IN THE BRAIN, WHICH MAY PRODUCE OR INDUCE PRODUCTION OF A NEUROTRANSMITTER, POSSIBLY DOPAMINE, THEREFORE ACTING SIMILARLY TO DOPAMINE REUPTAKE INHIBITOR TYPE ANTIDEPRESSANTS AND STIMULANTS.

CORRELATIONS HAVE BEEN FOUND BETWEEN LATENT Toxoplasma INFECTIONS AND VARIOUS CHARACTERISTICS:

  • DECREASED NOVELTY-SEEKING BEHAVIOUR
  • SLOWER REACTIONS
  • LOWER RULE-CONSCIOUSNESS AND JEALOUSY (IN MEN)
  • LESS FRIGIDITY AND GREATER CONSCIENTIOUSNESS (IN WOMEN)

STUDIES HAVE FOUND THAT TOXOPLASMOSIS IS ASSOCIATED WITH AN INCREASED CAR ACCIDENT RATE IN PEOPLE WITH RH-NEGATIVE BLOOD. THE CHANCE OF AN ACCIDENT RELATIVE TO UNINFECTED PEOPLE IS INCREASED ROUGHLY 2.5 TIMES.

THIS MAY BE DUE TO THE SLOWED REACTION TIMES THAT ARE ASSOCIATED WITH INFECTION. “IF OUR DATA ARE TRUE THEN ABOUT A MILLION PEOPLE A YEAR DIE JUST BECAUSE THEY ARE INFECTED WITH Toxoplasma”, THE RESEARCHER JAROSLAV FLEGR TOLD THE GUARDIAN. THE DATA SHOWS THAT THE RISK DECREASES WITH TIME AFTER INFECTION, BUT IS NOT DUE TO AGE. RUTH GILBERT, MEDICAL COORDINATOR OF THE EUROPEAN MULTICENTRE STUDY ON CONGENITAL TOXOPLASMOSIS, TOLD BBC NEWS ONLINE THESE FINDINGS COULD BE DUE TO CHANCE, OR DUE TO SOCIAL AND CULTURAL FACTORS ASSOCIATED WITH Toxoplasma INFECTION. HOWEVER THERE IS ALSO EVIDENCE OF A DELAYED EFFECT WHICH INCREASES REACTION TIMES.

OTHER STUDIES SUGGEST THAT THE PARASITE MAY INFLUENCE PERSONALITY. THERE ARE CLAIMS OF Toxoplasma CAUSING ANTISOCIAL ATTITUDES IN MEN AND PROMISCUITY (OR EVEN “SIGNS OF HIGHER INTELLIGENCE”) IN WOMEN, AND GREATER SUSCEPTIBILITY TO SCHIZOPHRENIA AND BIPOLAR DISORDER IN ALL INFECTED PERSONS. A 2004 STUDY FOUND THAT Toxoplasma “PROBABLY INDUCE[S] A DECREASE OF NOVELTY SEEKING.”

ACCORDING TO SYDNEY UNIVERSITY OF TECHNOLOGY INFECTIOUS DISEASE RESEARCHER NICKY BOULTER IN AN ARTICLE THAT APPEARED IN THE JANUARY/FEBRUARY 2007 EDITION OF AUSTRALASIAN SCIENCE MAGAZINE, Toxoplasma INFECTIONS LEAD TO CHANGES DEPENDING ON THE SEX OF THE INFECTED PERSON.

THE STUDY SUGGESTS THAT MALE CARRIERS HAVE SHORTER ATTENTION SPANS, A GREATER LIKELIHOOD OF BREAKING RULES AND TAKING RISKS, AND ARE MORE INDEPENDENT, ANTI-SOCIAL, SUSPICIOUS, JEALOUS AND MOROSE. IT ALSO SUGGESTS THAT THESE MEN ARE DEEMED LESS ATTRACTIVE TO WOMEN. WOMEN CARRIERS ARE SUGGESTED TO BE MORE OUTGOING, FRIENDLY, MORE PROMISCUOUS, AND ARE CONSIDERED MORE ATTRACTIVE TO MEN COMPARED WITH NON-INFECTED CONTROLS. THE RESULTS ARE SHOWN TO BE TRUE WHEN TESTED ON MICE, THOUGH IT IS STILL INCONCLUSIVE. A FEW SCIENTISTS HAVE SUGGESTED THAT, IF THESE EFFECTS ARE GENUINE, PREVALENCE OF TOXOPLASMOSIS COULD BE A MAJOR DETERMINANT OF CULTURAL DIFFERENCES.

TOXOPLASMA’S ROLE IN SCHIZOPHRENIA

THE POSSIBILITY THAT TOXOPLASMOSIS IS ONE CAUSE OF SCHIZOPHRENIA HAS BEEN STUDIED BY SCIENTISTS SINCE AT LEAST 1953. THESE STUDIES HAD ATTRACTED LITTLE ATTENTION FROM U.S. RESEARCHERS UNTIL THEY WERE PUBLICIZED THROUGH THE WORK OF PROMINENT PSYCHIATRIST AND ADVOCATE E. FULLER TORREY. IN 2003, TORREY PUBLISHED A REVIEW OF THIS LITERATURE, REPORTING THAT ALMOST ALL THE STUDIES HAD FOUND THAT SCHIZOPHRENICS HAVE ELEVATED RATES OF Toxoplasma INFECTION. A 2006 PAPER HAS EVEN SUGGESTED THAT PREVALENCE OF TOXOPLASMOSIS HAS LARGE-SCALE EFFECTS ON NATIONAL CULTURE. THESE TYPES OF STUDIES ARE SUGGESTIVE BUT CANNOT CONFIRM A CAUSAL RELATIONSHIP (BECAUSE OF THE POSSIBILITY, FOR EXAMPLE, THAT SCHIZOPHRENIA INCREASES THE LIKELIHOOD OF Toxoplasma INFECTION RATHER THAN THE OTHER WAY AROUND).

  • ACUTE Toxoplasma INFECTION SOMETIMES LEADS TO PSYCHOTIC SYMPTOMS NOT UNLIKE SCHIZOPHRENIA.
  • SOME ANTI-PSYCHOTIC MEDICATIONS THAT ARE USED TO TREAT SCHIZOPHRENIA, SUCH AS HALOPERIDOL, ALSO STOP THE GROWTH OF Toxoplasma IN CELL CULTURES.
  • SEVERAL STUDIES HAVE FOUND SIGNIFICANTLY HIGHER LEVELS OF Toxoplasma ANTIBODIES IN SCHIZOPHRENIA PATIENTS COMPARED TO THE GENERAL POPULATION.
  • Toxoplasma INFECTION CAUSES DAMAGE TO ASTROCYTES IN THE BRAIN, AND SUCH DAMAGE IS ALSO SEEN IN SCHIZOPHRENIA.

42-21781322

UN REVOLUCIONARIO TRATAMIENTO NO INVASIVO PARA EL CÁNCER DE MAMA SE DIÓ A CONOCER ESTE AÑO EN LA ROYAL SOCIETY SUMMER SCIENCE EXHIBITION. CIENTÍFICOS DIRIGIDOS POR EL EXPERTO EN CÁNCER DE MAMA DE RENOMBRE MUNDIAL, MO KESHTGAR, SON LOS PRIMEROS EN UTILIZAR LA TERAPIA FOTODINÁMICA (PDT) PARA TRATAR EL CÁNCER DE MAMA.

PDT (POR SUS SIGLAS EN INGLÉS), UTILIZA LA LUZ PARA DESTRUIR LAS CÉLULAS CANCEROSAS, SUPRIMIENDO LA NECESIDAD DE CIRUGÍA INVASIVA, Y POSIBLEMENTE OFRECIENDO UNA ALTERNATIVA A LA RADIOTERAPIA EN ALGUNOS CASOS. PDT TRABAJA DANDO AL PACIENTE UNA DROGA QUE HACE QUE LA ZONA OBJETIVO SEA SENSIBLE A LA LUZ. EL FÁRMACO SE ACTIVA CUANDO UNA LUZ DE LÁSER ROJO DE BAJA POTENCIA SE INCIDE EN LA ZONA. EL PROCESOS PRIVA A LAS CÉLULAS DE OXÍGENO, CAUSANDO SU MUERTE.

LOS ENSAYOS SE LLEVARÁN A CABO EN LONDRES EN EL ROYAL FREE HOSPITAL, DONDE KESHTGAR HA ESTADO TRABAJANDO CON UN EQUIPO TÉCNICO Y CIENTÍFICO QUE INCLUYE A STEPHEN BOWN DEL NATIONAL MEDICAL LASER CENTRE, UNIVERSITY COLLEGE LONDON Y A TAYYEBA HASAN DE LA HARVARD MEDICAL SCHOOL EN BOSTON, ESTADOS UNIDOS.

EL TRATAMIENTO YA ESTÁ DISPONIBLE PARA EL CÁNCER DE PIEL (NO MELANOMA), CÁNCER DE BOCA, Y ALGUNOS OTROS TIPOS DE CÁNCER. PERO EL EQUIPO ES EL PRIMERO EN APLICARLO AL CÁNCER DE MAMA. TAMBIÉN SE ESTÁN REALIZANDO ENSAYOS CON PDT PARA CÁNCER DE PRÓSTATA, DE BILIS, Y DE PÁNCREAS.

Follow

Get every new post delivered to your Inbox.